NPM1 Mutation Quantitative Kit

A quantitative molecular diagnostic kit for measuring NPM1 mutations. Provides quantitative assessment of NPM1 gene mutations for oncology and haematology applications.

A qualitative molecular diagnostic kit for NPM1 mutation detection. Designed for use in haematologic malignancy assessment and leukaemia diagnostics.

A diagnostic test kit for quantitative measurement of BCR-ABL fusion transcripts. This kit provides absolute quantification of BCR-ABL1 levels for disease monitoring and therapeutic response assessment in chronic myeloid leukemia.

A molecular diagnostic kit for MPL mutation detection. Used in haematology and oncology for identifying MPL gene mutations associated with myeloproliferative neoplasms.

A diagnostic kit for the detection of FLT3 mutations in haematologic samples. Used in oncology and haematology for identifying FLT3 gene alterations associated with acute myeloid leukaemia and other blood cancers.

PNAClamp™ Mutation Detection Kit for IDH1 enables rapid identification of IDH1 mutations in clinical samples using peptide nucleic acid (PNA) clamp technology. This kit is designed for molecular diagnostics in oncology and hematology applications, providing sensitive and specific mutation detection for research and clinical laboratory use.

A diagnostic kit for investigating mutations associated with Acute Myeloid Leukemia (AML). Enables molecular precision diagnostics for hemato-oncology applications.

Molecular diagnostic kit for screening leukemia-associated fusion genes using nucleic acid analysis. Enables detection of chromosomal abnormalities in blood and bone marrow samples to support leukemia diagnosis and classification. Utilizes advanced molecular techniques to identify clinically relevant fusion gene targets.

A multiplex PCR panel kit for acute myeloid leukaemia diagnostics. Used in haematology and oncology for comprehensive detection of multiple AML-associated mutations and markers.

PNAClamp™ Mutation Detection Kit IDH2 is a molecular diagnostic test for detecting IDH2 mutations using peptide nucleic acid (PNA) clamping technology. This kit enables rapid and accurate identification of IDH2 gene mutations in clinical samples, supporting diagnosis and treatment planning for hematologic malignancies and other IDH2-associated conditions.

A diagnostic panel kit for myeloproliferative neoplasm testing. Designed to detect multiple MPN-associated mutations and markers in a single comprehensive test.

A multiplex PCR panel kit for acute leukaemia diagnostics. Designed for comprehensive detection of multiple mutations and markers associated with acute leukaemias.